Trials / Completed
CompletedNCT03309839
HLA-DR Expression in Neonates After Cardiac Surgery Under Cardiopulmonary Bypass
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 28 Days
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in neonates who underwent cardiac surgery with cardiopulmonary bypasss. We hypothesize that HLA-DR expression in neonates is predictive of septic complications after cardiopulmonary bypass
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood collection | A sample of an additional blood tube will be taken in parallel with the blood test carried out for the treatment. |
Timeline
- Start date
- 2018-01-29
- Primary completion
- 2019-03-14
- Completion
- 2019-04-13
- First posted
- 2017-10-16
- Last updated
- 2021-09-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03309839. Inclusion in this directory is not an endorsement.